Amgen announced that Repatha (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse cardiovascular (CV) events (MACE) in… read more.
NICE(UK): Acoramidis can be used, within its marketing authorisation, as an option to treat wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults. Acoramidis can only be used… read more.
People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and… read more.
Nearly 1 in 2 Americans has high blood pressure—sometimes called the “silent killer” because it harms the heart and blood vessels—but many people don’t know they have it…. read more.
Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority. An echocardiogram, or cardiac ultrasound, is one of the most commonly used imaging tools employed by… read more.
People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get… read more.
High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease and stroke. For decades, researchers have observed that premenopausal women are less likely to develop high blood pressure than men or postmenopausal… read more.
Washington State University researchers have developed a 3D-printed model of the left side of the heart that contracts and beats, offering the chance for surgeons and medical students… read more.
BD (Becton, Dickinson and Company) announced it has obtained CE Marking for the Revello Vascular Covered Stent, a next-generation endovascular solution for the treatment of atherosclerotic lesions in… read more.
A single 25 mg dose of a combination of amphetamine-dextroamphetamine salts (Adderall) can have measurable cardiovascular effects in healthy young adults, a Mayo Clinic study found. Researchers, whose findings are published in Mayo Clinic… read more.
Driven by rising rates in high blood pressure, nearly 6 in 10 women in the U.S. will have some type of cardiovascular disease (CVD) in the next 25 years, according to… read more.
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
